Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections
NCT07593547 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 790
Last updated 2026-05-18
Summary
The goal of this multicentre observational study is to analyse the treatment strategies and the outcomes for patients with S. maltophilia infections using target trial emulation methodology. The main question it aims to answer is:
• Does combined therapy achieve better results than monotherapy in treating S. maltophilia infections?
Researchers will compare groups receiving monotherapy and combined therapy to see if there are differences in all-cause 30-day mortality.
Conditions
- S. Maltophilia Infection
- Bloodstream Infection
- Pneumonia - Bacterial
Sponsors & Collaborators
-
Instituto de Investigación Sanitaria Gregorio Marañón
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-06
- Primary Completion
- 2026-09-01
- Completion
- 2026-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins
NCT04478721 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia
NCT01968733 ·Status: COMPLETED ·Phase: PHASE3
-
Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis
NCT00871104 ·Status: COMPLETED ·Phase: PHASE4
-
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
NCT04310930 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Cefiderocol vs Best Available Therapy for Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex Infections: A Target Trial Emulation
NCT07226557 ·Status: ACTIVE_NOT_RECRUITING
-
Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems
NCT04876430 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME)
NCT01597973 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
NCT00633152 ·Status: COMPLETED ·Phase: PHASE2
-
Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia
NCT07155590 ·Status: ACTIVE_NOT_RECRUITING
-
Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae
NCT02795949 ·Status: COMPLETED ·Phase: PHASE3
-
Multicentric Study About the Usefulness of Monitoring Plasma Levels of Colistin and Sodium Colistimethate in Patients With Infections Due to Multi-drug Resistant Gram Negative Bacilli, Treated With Colistin
NCT01845246 ·Status: COMPLETED ·Phase: NA
-
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
NCT00423657 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
NCT01898338 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of a Short-term Sequential Therapy in Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.
NCT01875263 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis
NCT05887908 ·Status: COMPLETED ·Phase: PHASE3
-
Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection
NCT04238390 ·Status: WITHDRAWN ·Phase: PHASE3
-
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus
NCT02701595 ·Status: COMPLETED ·Phase: PHASE3
-
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
NCT05922124 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia
NCT02679573 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections
NCT00303589 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis
NCT03681431 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic Study of Linezolid for TB Meningitis
NCT03537495 ·Status: COMPLETED ·Phase: PHASE2
-
FiH Study to Assess Safety and PK of SAD and MAD of ANT3310 Alone and in Combination With Meropenem in Healthy Subjects
NCT05905913 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)
NCT02452047 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections.
NCT00555061 ·Status: COMPLETED ·Phase: PHASE4